1. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients.
- Author
-
Higashi Y, Momotani Y, Suzuki E, and Kaku T
- Subjects
- Antipsychotic Agents adverse effects, Antipsychotic Agents blood, Dibenzothiepins adverse effects, Dibenzothiepins blood, Erythrocytes metabolism, Humans, Psychiatric Status Rating Scales, Schizophrenia physiopathology, Schizophrenic Psychology, Antipsychotic Agents therapeutic use, Dibenzothiepins therapeutic use, Electroencephalography, Schizophrenia drug therapy
- Abstract
The overall effect of zotepine was a "slightly improved" or better response in 20 patients (64.5%), "unchanged" in 10 (32.3%) and "worsened" in 1 (3.2%). Zotepine exhibited some degree of improvement in 54.5% of patients unresponsive to prior drugs. The onset of effect of zotepine was within one month in 19 patients. The improvement rate in the hebephrenic type (66.7%) was almost the same as in the paranoid type. The improvement rate classified by psychopathology was highest for hypobulia, followed by restlessness-excitement and hallucination, depressive mood, hypochondria and delusion. The side-effects were subjective complaints, such as general fatigue, dryness of mouth, sleepiness or fainting in a small number of cases. There was a slight increase in S-GPT in one patient and a slightly increased blood platelet count, also in one patient. Serial EEG changes associated with zotepine studied in another 17 chronic schizophrenics could be classified into three groups: those with increased slow waves, those with enhanced alpha waves and those with unchanged EEGs. There was a positive correlation between the incidence of slow waves and higher plasma levels of zotepine.
- Published
- 1987
- Full Text
- View/download PDF